| Property | Value |
|
overview
|
Dr. Immergluck is a pediatrician, a pediatric infectious disease specialist, and population health service researcher, who has spent over 25 years studying the impact of antibiotic resistant infections and vaccine preventable conditions in children. At UCM, she will focus on clinical vaccine and infectious disease related therapeutic trials and public health matters related to the prevention of infectious diseases among medically underserved populations including how SDOH factors influence the spread of infections.
She received her B.A. degree from Northwestern University in Evanston, Illinois and received her medical degree from The Ohio State University College of Medicine in 1990. Once completing her residency in Pediatrics at the University of Chicago Children’s Hospital, she also completed a fellowship in Pediatric Infectious Diseases at the University of Chicago. She was a recipient of the Pediatric Scientist Development Award in 1994, where she developed a primary neuronal model to study requirements for herpes simplex entry, working with Dr. Nancy B. Schwartz.
Dr. Immergluck served as an Assistant Professor of Pediatrics at the University of Illinois at Chicago from 1996-2002 and subsequently as Associate Professor of Pediatrics at Michigan State University serving as Director of the Pediatric Infectious Diseases Program at DeVos Children’s Hospital from 2002-2005. Most recently, Dr. Immergluck served as a Professor and Physician Scientist at Morehouse School of Medicine, Director of the Pediatric Clinical Translational Research Unit and the Vaccine Trial Unit at the Clinical Research Center, and site Principal Investigator for its participation in the U.S. COVID-19 Prevention Network, including COVID-19 Vaccine Clinical Trials. Concurrently, she served as an adjunct Associate Professor at Emory University's Rollins School of Public Health and Research Director for the Pediatric Emergency Medicine Associates group in Atlanta, Georgia. Over the last decade, she has addressed how children’s socio ecological conditions impact their health and wellness with emphasis on conditions and diseases which disproportionately affect children of color, e.g., asthma, sickle cell. In 2012, she received her Master of Science in Clinical Research and in 2015, working with her mentors (Dr. George S. Rust and Dr. Lance A. Waller) she was awarded a five-year K08 grant from the Agency for Healthcare Research and Quality to apply geospatial statistical modeling to understand the impact of socio environmental factors which affect the transmission and spread of community associated antibiotic resistance infections in otherwise healthy children.
Dr. Immergluck serves on the American Academy of Pediatrics, Executive Board for the Section on Infectious Diseases, and is committed to increase the diversity in pipeline programs for the next generation of biomedical scientists and physician scientists.
|